News Headlines Article

Majority stake in East Bay’s MedeAnalytics being sold to big private equity firm
San Francisco Business Times

Thomas Bravo LLC has agreed to buy a majority stake in MedeAnalytics Inc., an Emeryville-based health care software and consulting firm, for an undisclosed price. Bain Capital Integral Investors LLC and Emergence Capital Partners will remain as minority shareholders, officials said. They earlier invested $57 million. The deal is expected to close within 30 days. Thomas Bravo manages private equity funds totaling $8.5 billion in commitments.